[go: up one dir, main page]

MA38975A1 - Dispositif d'administration par voie intra-utérine - Google Patents

Dispositif d'administration par voie intra-utérine

Info

Publication number
MA38975A1
MA38975A1 MA38975A MA38975A MA38975A1 MA 38975 A1 MA38975 A1 MA 38975A1 MA 38975 A MA38975 A MA 38975A MA 38975 A MA38975 A MA 38975A MA 38975 A1 MA38975 A1 MA 38975A1
Authority
MA
Morocco
Prior art keywords
delivery device
intrauterine delivery
intrauterine
utérine
contraception
Prior art date
Application number
MA38975A
Other languages
English (en)
Inventor
Norbert Schmees
Katja Prelle
Bernhard Lindenthal
Ulrike Fuhrmann
Manja Ahola
Christine Talling
Lüder M Fels
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of MA38975A1 publication Critical patent/MA38975A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A61F6/144—Wirelike structures, e.g. loops, rings, spirals with T-configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La présente invention concerne une méthode de contraception améliorée qui remédie aux problèmes posés par les saignements initiaux et les saignements vaginaux légers associés à l'utilisation de dispositifs d'administration par voie intra-utérine, ainsi qu'un dispositif d'administration par voie intra-utérine.
MA38975A 2013-10-21 2014-10-14 Dispositif d'administration par voie intra-utérine MA38975A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13397533 2013-10-21
PCT/EP2014/071990 WO2015055635A1 (fr) 2013-10-18 2014-10-14 Dispositif d'administration par voie intra-utérine

Publications (1)

Publication Number Publication Date
MA38975A1 true MA38975A1 (fr) 2017-11-30

Family

ID=49584678

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38975A MA38975A1 (fr) 2013-10-21 2014-10-14 Dispositif d'administration par voie intra-utérine

Country Status (19)

Country Link
US (1) US20160262923A1 (fr)
EP (1) EP3057573A1 (fr)
JP (1) JP2016539088A (fr)
KR (1) KR20160072114A (fr)
CN (1) CN105636577A (fr)
AU (1) AU2014336286A1 (fr)
CA (1) CA2927750A1 (fr)
CR (1) CR20160176A (fr)
CU (1) CU20160051A7 (fr)
DO (1) DOP2016000089A (fr)
IL (1) IL244508A0 (fr)
MA (1) MA38975A1 (fr)
MX (1) MX2016004930A (fr)
PE (1) PE20160534A1 (fr)
PH (1) PH12016500620A1 (fr)
SG (1) SG11201601688WA (fr)
TN (1) TN2016000134A1 (fr)
UY (1) UY35788A (fr)
WO (1) WO2015055635A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU201617347S (en) * 2016-12-23 2017-01-23 Jurox Pty Ltd intravaginal device
US11666552B2 (en) * 2017-09-27 2023-06-06 Bayer Oy Method for modifying release of a therapeutically active agent from an elastomeric matrix
US11571329B2 (en) 2019-11-21 2023-02-07 Coopersurgical, Inc. Packaging systems for implantable devices and related methods
US11338119B2 (en) * 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) * 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
CN112472975B (zh) * 2020-11-19 2022-04-12 华中科技大学 一种宫内药物控释系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107339B (fi) * 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
RU2302883C2 (ru) * 2001-08-31 2007-07-20 Шеринг Ой Система доставки лекарств
DE10145269A1 (de) * 2001-09-14 2003-04-17 Siegfried R Riek Intrauterine Vorrichtung mit einem oder mehreren Pharmakadepots und integrierten Stellmitteln zur Variation der Abgabedosis
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
FI20085277A0 (fi) * 2008-04-02 2008-04-02 Bayer Schering Pharma Oy Kohdunsisäinen järjestelmä
EP2140860A1 (fr) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy Procédé de contraception amélioré

Also Published As

Publication number Publication date
JP2016539088A (ja) 2016-12-15
TN2016000134A1 (en) 2017-10-06
CU20160051A7 (es) 2016-07-29
CA2927750A1 (fr) 2015-04-23
MX2016004930A (es) 2016-06-28
KR20160072114A (ko) 2016-06-22
UY35788A (es) 2015-05-29
WO2015055635A1 (fr) 2015-04-23
CR20160176A (es) 2016-07-01
IL244508A0 (en) 2016-04-21
EP3057573A1 (fr) 2016-08-24
CN105636577A (zh) 2016-06-01
PE20160534A1 (es) 2016-06-15
US20160262923A1 (en) 2016-09-15
PH12016500620A1 (en) 2016-06-13
AU2014336286A1 (en) 2016-03-24
DOP2016000089A (es) 2016-09-15
SG11201601688WA (en) 2016-05-30

Similar Documents

Publication Publication Date Title
MA38975A1 (fr) Dispositif d'administration par voie intra-utérine
BR112015028722A2 (pt) interface de componente de sistema de detecção remota distribuída
CL2019000935A1 (es) Composición farmacéutica, métodos para tratamiento y usos de la misma.
EA201891055A1 (ru) Устройства для защиты от травматического повреждения головного мозга
MX2019009175A (es) Interfaces de programacion de aplicacion, de aplicacion de comunicacion de terceros.
MX2016005017A (es) Metodos para el tratamiento de condiciones asociadas con la activacion del complemento dependiente de masp-2.
ZA201603342B (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
AR095639A1 (es) Método y sistema para transferir configuraciones de un usuario a otro dispositivo receptor del usuario con el uso de un dispositivo móvil del usuario
CL2017001135A1 (es) Anticuerpos mejorados contra il-6
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
MX2016000158A (es) Dispositivo de oclusion con canal con posibilidad de apertura.
MA41116B1 (fr) Compositions sélectives d'inhibiteur il-6-trans-signalisation
CL2017001957U1 (es) Almohadilla urinaria masculina.
MX2020012800A (es) Cannabinoides y usos de los mismos.
EP3995091A4 (fr) Dispositif et système de curetage utérin à avortement à vision directe
CL2015002785A1 (es) Método y sistema para transferir configuraciones de un usuario a otro dispositivo receptor del usuario
EA201591892A1 (ru) Модуляторы прогестероновых рецепторов для применения в лечении фибромы матки
CL2015003434A1 (es) Composición farmacéutica, su uso y régimen de administración para contracepción a demanda.
TR201907922T4 (tr) Düşük tehdidinin veya erken doğumun tedavisine veya önlenmesine yönelik lipoik asit.
MA53533A1 (fr) Conjugué persistant d'un triple activateur activant le récepteur du glucagon, du glp-1 et du gip
MX2014012849A (es) USO INTRAUTERINO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-E N-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA.
UA100789U (uk) Спосіб лікування пацієнток з аномальними матковими кровотечами на тлі антикоагуляційної терапії
AR098060A1 (es) Sistema de administración intrauterina
UA112346C2 (uk) Спосіб поліпшення когнітивних функцій у породілей при кесаревому розтині
IN2013MU02732A (fr)